FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3209313240> ?p ?o ?g. }

• W3209313240 endingPage "e68" @default.
• W3209313240 startingPage "e61" @default.
• W3209313240 abstract "Although health-related quality of life (HR-QoL) outcomes are pivotal in oncology, the prognostic significance of patient-reported HR-QoL metrics is largely undefined in localised prostate cancer. We report the association of baseline HR-QoL metrics with overall survival and toxicity in localised prostate cancer.This was a secondary analysis of a phase III randomised controlled study conducted in a single-payer health system. Patients with Gleason score ≤7, clinical stage T1b-T3a and prostate-specific antigen <30 ng/ml were randomised to neoadjuvant and concurrent androgen deprivation therapy (ADT) for 6 months starting 4 months before prostate radiotherapy or concurrent and adjuvant ADT for 6 months starting simultaneously with prostate radiotherapy. HR-QoL scores were estimated using the European Organisation for Research and Treatment of Cancer QoL questionnaire. A multistate Markov model was used to determine the association of baseline HR-QoL metrics with overall survival and a multilevel multivariable Cox regression was used to determine the association with the incidence of delayed-onset grade ≥3 radiotherapy-related toxicities. To adjust for multiple analyses, P < 0.025 was considered as statistically significant.Overall, 393 patients with baseline HR-QoL data were included in this analysis: 194 in the neoadjuvant arm and 199 in the adjuvant arm. Baseline financial difficulty (hazard ratio 1.020, 95% confidence interval 1.010-1.030, P = 0.02) and dyspnoea (hazard ratio 1.020, 95% confidence interval 1.003-1.030, P = 0.01) were associated with inferior overall survival. Baseline dyspnoea was associated with a higher incidence of grade ≥3 toxicity (hazard ratio 1.020, 95% confidence interval 1.010-1.030, P = 0.023).In a cohort of localised prostate cancer patients treated with radiotherapy and short-term ADT, a 10-point higher baseline financial difficulty or dyspnoea was associated with a 20% increased risk of death. With each 10-point increase in baseline dyspnoea, we noted a 20% increase in the associated risk of grade ≥3 delayed-onset radiotherapy-related toxicity." @default.
• W3209313240 created "2021-11-08" @default.
• W3209313240 creator A5025965023 @default.
• W3209313240 creator A5027101830 @default.
• W3209313240 creator A5043559301 @default.
• W3209313240 creator A5066517502 @default.
• W3209313240 creator A5070757819 @default.
• W3209313240 creator A5073836342 @default.
• W3209313240 creator A5076238068 @default.
• W3209313240 creator A5082004047 @default.
• W3209313240 date "2022-01-01" @default.
• W3209313240 modified "2023-10-13" @default.
• W3209313240 title "Association of Baseline Patient-reported Health-related Quality of Life Metrics with Outcome in Localised Prostate Cancer" @default.
• W3209313240 cites W1993324234 @default.
• W3209313240 cites W1997253444 @default.
• W3209313240 cites W2007750086 @default.
• W3209313240 cites W2012745445 @default.
• W3209313240 cites W2049234867 @default.
• W3209313240 cites W2098660029 @default.
• W3209313240 cites W2099037568 @default.
• W3209313240 cites W2113676999 @default.
• W3209313240 cites W2131170102 @default.
• W3209313240 cites W2139562398 @default.
• W3209313240 cites W2142200772 @default.
• W3209313240 cites W2144336515 @default.
• W3209313240 cites W2204695292 @default.
• W3209313240 cites W2298128274 @default.
• W3209313240 cites W2409923755 @default.
• W3209313240 cites W2461891724 @default.
• W3209313240 cites W2463523822 @default.
• W3209313240 cites W2471106902 @default.
• W3209313240 cites W2541722967 @default.
• W3209313240 cites W2766605453 @default.
• W3209313240 cites W2783091042 @default.
• W3209313240 cites W2883669791 @default.
• W3209313240 cites W2884970318 @default.
• W3209313240 cites W2996677572 @default.
• W3209313240 cites W3048376523 @default.
• W3209313240 cites W3093207858 @default.
• W3209313240 cites W3126460251 @default.
• W3209313240 doi "https://doi.org/10.1016/j.clon.2021.10.007" @default.
• W3209313240 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34728131" @default.
• W3209313240 hasPublicationYear "2022" @default.
• W3209313240 type Work @default.
• W3209313240 sameAs 3209313240 @default.
• W3209313240 citedByCount "1" @default.
• W3209313240 countsByYear W32093132402023 @default.
• W3209313240 crossrefType "journal-article" @default.
• W3209313240 hasAuthorship W3209313240A5025965023 @default.
• W3209313240 hasAuthorship W3209313240A5027101830 @default.
• W3209313240 hasAuthorship W3209313240A5043559301 @default.
• W3209313240 hasAuthorship W3209313240A5066517502 @default.
• W3209313240 hasAuthorship W3209313240A5070757819 @default.
• W3209313240 hasAuthorship W3209313240A5073836342 @default.
• W3209313240 hasAuthorship W3209313240A5076238068 @default.
• W3209313240 hasAuthorship W3209313240A5082004047 @default.
• W3209313240 hasConcept C121608353 @default.
• W3209313240 hasConcept C126322002 @default.
• W3209313240 hasConcept C143998085 @default.
• W3209313240 hasConcept C159110408 @default.
• W3209313240 hasConcept C207103383 @default.
• W3209313240 hasConcept C2777899217 @default.
• W3209313240 hasConcept C2779951463 @default.
• W3209313240 hasConcept C2780192828 @default.
• W3209313240 hasConcept C44249647 @default.
• W3209313240 hasConcept C50382708 @default.
• W3209313240 hasConcept C509974204 @default.
• W3209313240 hasConcept C71924100 @default.
• W3209313240 hasConceptScore W3209313240C121608353 @default.
• W3209313240 hasConceptScore W3209313240C126322002 @default.
• W3209313240 hasConceptScore W3209313240C143998085 @default.
• W3209313240 hasConceptScore W3209313240C159110408 @default.
• W3209313240 hasConceptScore W3209313240C207103383 @default.
• W3209313240 hasConceptScore W3209313240C2777899217 @default.
• W3209313240 hasConceptScore W3209313240C2779951463 @default.
• W3209313240 hasConceptScore W3209313240C2780192828 @default.
• W3209313240 hasConceptScore W3209313240C44249647 @default.
• W3209313240 hasConceptScore W3209313240C50382708 @default.
• W3209313240 hasConceptScore W3209313240C509974204 @default.
• W3209313240 hasConceptScore W3209313240C71924100 @default.
• W3209313240 hasFunder F4320307770 @default.
• W3209313240 hasIssue "1" @default.
• W3209313240 hasLocation W32093132401 @default.
• W3209313240 hasLocation W32093132402 @default.
• W3209313240 hasOpenAccess W3209313240 @default.
• W3209313240 hasPrimaryLocation W32093132401 @default.
• W3209313240 hasRelatedWork W2030798726 @default.
• W3209313240 hasRelatedWork W2133235702 @default.
• W3209313240 hasRelatedWork W2318819988 @default.
• W3209313240 hasRelatedWork W2466734156 @default.
• W3209313240 hasRelatedWork W2793295628 @default.
• W3209313240 hasRelatedWork W2896128085 @default.
• W3209313240 hasRelatedWork W3199292628 @default.
• W3209313240 hasRelatedWork W4220991042 @default.
• W3209313240 hasRelatedWork W4221041809 @default.
• W3209313240 hasRelatedWork W95247034 @default.
• W3209313240 hasVolume "34" @default.
• W3209313240 isParatext "false" @default.

• next